North America Superdisintegrants Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis and Forecasts by Type (Synthetic Superdisintegrants, Natural Superdisintegrants, Other Superdisintegrants); Formulation (Tablets, Capsules); Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Other Diseases), and Country


No. of Pages: 167    |    Report Code: TIPRE00009244    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
North America Superdisintegrants Market
Buy Now

North America, the superdisintegrants market, is anticipated to reach US$ 248.18 Mn in 2027 from US$ 136.37 Mn in 2019. The market is projected to grow with a CAGR of 7.9% from 2020-2027.

 

The rise of the superdisintegrants market is driven by factors such as the increasing prevalence of neurological diseases and benefits offered by generic drugs are boosting the market over the years. Although, pricing pressure on drug manufacturers is likely to hinder the growth of the market in the future years.

 

The region is witnessing exponential growth in the prevalence of chronic diseases. Factors such as the progression of viruses, bacteria, parasites, coupled with the growing adoption of a sedentary lifestyle, genetic conditions, and consumption of poor diet, are responsible for the increasing prevalence of these diseases. Also, oral drug delivery remains the most common route of drug administration in the healthcare world. Solid dosage forms typically include tablets, capsules, and powders for the treatment of particular disease conditions. Moreover, the growing emphasis on novel drug delivery approach is expected to boost awareness and focus on the utilization of orally disintegrating tablets during the forecast period. Superdisintegrants or orally disintegrating tablets are gaining traction due to advantages such as ease of drug administration and better compliance for pediatric and geriatric patients.

 

Furthermore, superdisintegrant tablets offer several benefits over traditional capsules and tablets. Advantages of disintegrants include an ability for accurate dosing, fast action, superior patient compliance, better palatability, and cost-effectiveness, as well as ease of administration, no risk of airway suffocation during swallowing, and flexibility in terms of large and small molecules. Such salient features of superdisintegrant tablets represent a massive potential for its adoption during tablet formulations. Thus, owing to the above-mentioned factors, the demand for superdisintegrants is increasing, which is anticipated to grow the market in the coming years.

 

In 2019, the US accounted for the largest market share in North America superdisintegrants market, and it is also expected to grow at a faster pace over the forecast period. US is an economically advanced country, and the country has the presence of various players that are well established in the pharmaceutical market. The companies are engaged in the research and development activities that are enabling them to develop the latest drugs for the diseases. Hence, considering the mentioned factors, the superdisintegrants market is expected to grow at a significant pace in the US during the forecast period.

 

US Superdisintegrants Market Revenue and Forecasts to 2027 (US$ Mn)

US Superdisintegrants Market
Get more information on this report

North America Superdisintegrants Strategic Insights

Strategic insights for the North America Superdisintegrants provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/north-america-superdisintegrantsmarket-strategic-framework.webp
Get more information on this report

North America Superdisintegrants Report Scope

Report Attribute Details
Market size in 2019 US$ 136.37 Million
Market Size by 2027 US$ 248.18 Million
Global CAGR (2020 - 2027) 7.9%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Type
  • Synthetic Superdisintegrants
  • Natural Superdisintegrants
  • Other Superdisintegrants
By Formulation
  • Tablets
  • Capsules
By Therapeutic Area
  • Neurological Diseases
  • Gastrointestinal Diseases
  • Oncology
  • Inflammatory Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Other Diseases
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Ashland,
  • BASF SE
  • DowDupont Inc.
  • JRS PHARMA
  • COREL PHARMA CHEM
  • Roquette Frères
  • Asahi Kasei Corporation
  • Merck KGaA
  • Avantor, Inc.
  • DFE Pharma
  • Get more information on this report

    North America Superdisintegrants Regional Insights

    The geographic scope of the North America Superdisintegrants refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/north-america-superdisintegrantsmarket-geography.webp
    Get more information on this report

     

    NORTH AMERICA COLORECTAL CANCER – MARKET SEGMENTATION

     

    North America Colorectal Cancer Market - By Type

    • Synthetic Superdisintegrants
      • Crospovidone
      • Modified Starch
      • Modified Cellulose
      • Calcium Silicates
      • Ion Exchange Resins
    • Natural Superdisintegrants
    • Other Superdisintegrants

     

    North America Colorectal Cancer Market - By Formulation

    • Tablets
    • Capsules

     

    North America Colorectal Cancer Market - By Therapeutic Area

    • Neurological Diseases
    • Gastrointestinal Diseases
    • Oncology
    • Inflammatory Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Other Diseases

     

    North America Colorectal Cancer Market - By Geography

    • North America

      • US
      • Canada
      • Mexico


    Company Profiles

    • Ashland,
    • BASF SE
    • DowDupont Inc.
    • JRS PHARMA
    • COREL PHARMA CHEM
    • Roquette Frères
    • Asahi Kasei Corporation
    • Merck KGaA
    • Avantor, Inc.
    • DFE Pharma

    The List of Companies - North America Superdisintegrants Market

    The List of Companies - North America Superdisintegrants Market

    1. Ashland,
    2. BASF SE
    3. DowDupont Inc.
    4. JRS PHARMA
    5. COREL PHARMA CHEM
    6. Roquette Frères
    7. Asahi Kasei Corporation
    8. Merck KGaA
    9. Avantor, Inc.
    10. DFE Pharma

     

    Frequently Asked Questions
    How big is the North America Superdisintegrants Market?

    The North America Superdisintegrants Market is valued at US$ 136.37 Million in 2019, it is projected to reach US$ 248.18 Million by 2027.

    What is the CAGR for North America Superdisintegrants Market by (2020 - 2027)?

    As per our report North America Superdisintegrants Market, the market size is valued at US$ 136.37 Million in 2019, projecting it to reach US$ 248.18 Million by 2027. This translates to a CAGR of approximately 7.9% during the forecast period.

    What segments are covered in this report?

    The North America Superdisintegrants Market report typically cover these key segments-

    • Type (Synthetic Superdisintegrants, Natural Superdisintegrants, Other Superdisintegrants)
    • Formulation (Tablets, Capsules)
    • Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Other Diseases)

    What is the historic period, base year, and forecast period taken for North America Superdisintegrants Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Superdisintegrants Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Superdisintegrants Market?

    The North America Superdisintegrants Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Ashland,
  • BASF SE
  • DowDupont Inc.
  • JRS PHARMA
  • COREL PHARMA CHEM
  • Roquette Frères
  • Asahi Kasei Corporation
  • Merck KGaA
  • Avantor, Inc.
  • DFE Pharma
  • Who should buy this report?

    The North America Superdisintegrants Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Superdisintegrants Market value chain can benefit from the information contained in a comprehensive market report.